FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely oncology, and may be used for the purpose of the integrated treatment of the patients with II-IV breast cancer. That is ensured by administering cytostatic preparations after the one-stage chemotherapy, including: cyclophosphan (500 mg/m2) and doxorubicin (50 mg/m2) (the schedule AC) or cyclophosphan (500 mg/m2), doxorubicin (50 mg/m2) and fluorouracil (500 mg/m2) (the schedule FAC) intravenously. Besides, the preparation Panagen in the form of gastroenteric-coated tablets 30 mg/day is regularly divided over an active period of day that makes one tablet of the preparation Panagen for six times every two hours; the administration starts on the third day following the chemotherapy. The length of the administration of the preparation Panagen is 17 days and continued until the chemotherapeutic courses according to the above schedules completed.
EFFECT: method enables the higher clinical effectiveness in breast cancer that ensures preserving and stimulating granulocyte-macrophage and lymphocyte hematopoietic lineages that makes compensation for the negative effect of leukoreducing effect of the cytostatic preparations.
1 cl, 40 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING CANCER | 2009 |
|
RU2429019C2 |
METHOD FOR TREATING ONCOLOGICAL DISEASES | 2018 |
|
RU2675233C1 |
METHOD OF CANCER TREATMENT | 2007 |
|
RU2345792C2 |
METHOD OF OBTAINING STIMULATED DENDRITE CELLS FOR INDUCTION OF IMMUNE RESPONSE AGAINST HUMAN TUBERCULOSIS | 2009 |
|
RU2401664C1 |
ONCOTHERAPY | 2008 |
|
RU2387456C1 |
METHOD OF TREATING ONCOLOGICAL DISEASES | 2010 |
|
RU2489169C2 |
METHOD FOR STIMULATING ENDOGENOUS PRODUCTION OF CYTOKINES AND HEMOPOIETINS | 2012 |
|
RU2498821C1 |
PREPARATION ELICITING ANTITUMOR, ANTITOXIC AND RADIOPROTECTING EFFECT | 2003 |
|
RU2234323C1 |
METHOD FOR ERADICATION OF INITIATING CANCER STEM CELLS | 2013 |
|
RU2542410C1 |
BIOMEDICAL CELL PRODUCT FOR THE TREATMENT OF ONCOLOGICAL, NEURODEGENERATIVE, AUTOIMMUNE DISEASES AND INJURIES OF THE BRAIN AND SPINAL CORD | 2021 |
|
RU2798554C2 |
Authors
Dates
2013-08-20—Published
2012-01-26—Filed